PD2

General Information


DRACP ID  DRACP05716

Peptide Name   PD2

Sequence  RGDRLDRRDLRLDRRDLRC

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C97H175N43O30S

Absent amino acids  AEFHIKMNPQSTVWY

Common amino acids  R

Mass  277704

Pl  11.66

Basic residues  8

Acidic residues  5

Hydrophobic residues  4

Net charge  3

Boman Index  -14106

Hydrophobicity  -190.53

Aliphatic Index  82.11

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23384441

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2779

DRACP is developed by Dr.Zheng's team.